Xeljanz & Xeljanz XR Class Action

Xeljanz & Xeljanz XR

We are currently investigating a potential class action on behalf of all Canadians who were prescribed and ingested XELJANZ and/or XELJANZ XR (tofacitinib), and subsequently suffered serious heart-related problems (heart attack, stroke, or cardiovascular death), blood clots and/or cancer (malignancies).

Contact Us

For any inquiries with respect to this potential class action, please contact us directly by email or by phone at 1-844-672-5666. If corresponding by email, be sure to include your name, your telephone number and a brief message.